PSYC (PSYC) DeferredTaxAndRevenue: $0.00 Mil (As of Jun. 2017)


What is PSYC DeferredTaxAndRevenue?

PSYC PSYC DeferredTaxAndRevenue is $0.00 Mil as of Jun. 2017.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

PSYC's current deferred tax and revenue for the quarter that ended in Jun. 2017 was $0.00 Mil.

PSYC DeferredTaxAndRevenue Related Terms

PSYC DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for PSYC's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PSYC DeferredTaxAndRevenue Chart

PSYC Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec16
DeferredTaxAndRevenue
0.00 0.00 0.00 0.00 0.00

PSYC Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Dec14 Mar15 Jun15 Sep15 Mar16 Jun16 Sep16 Dec16 Jun17
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $0.00 Mil mean?
PSYC (PSYC) has a DeferredTaxAndRevenue of $0.00 Mil as of Jun. 2017. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on PSYC.
Is PSYC's DeferredTaxAndRevenue too high?
PSYC's current DeferredTaxAndRevenue is $0.00 Mil.
How does PSYC's DeferredTaxAndRevenue compare to ARLO and TAQR?
PSYC's DeferredTaxAndRevenue of $0.00 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Media - Diversified company?
A good DeferredTaxAndRevenue depends on the Media - Diversified industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on PSYC. PSYC's current DeferredTaxAndRevenue is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PSYC stock overvalued right now?
PSYC (PSYC) has a current DeferredTaxAndRevenue of $0.00 Mil. The current DeferredTaxAndRevenue is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For PSYC (PSYC), the current DeferredTaxAndRevenue is $0.00 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PSYC Business Description

Address 2881 South Valley View Boulevard, Suite 9, Las Vegas, NV, USA, 89102
PSYC Corp is a media-focused company serving the expanding industry and community of medicinal psychedelics. Through its media platform, Psychedelic Spotlight, the company has positioned itself right at the very core. These platforms provide the Company with an opportunity to dominate the intersection of cannabis and psychedelics as a media leader. Along with its subsidiary, the group offers public relations and media-focused services to companies within the medicinal psychedelics industry and other niche industries that include cannabis, holistic health, mining and precious metals, and others.